Immune-enrichment of insulin in bio-fluids on gold-nanoparticle decorated target plate and in situ detection by MALDI MS

被引:11
作者
Liang, Kai [1 ]
Wu, Hongmei [1 ,2 ]
Li, Yan [1 ]
机构
[1] Chinese Acad Sci, Inst Biophys, Lab Interdisciplinary Res, Beijing 100101, Peoples R China
[2] GuangDong Biohealtech Adv Co Ltd, Foshan 52800, Guangdong, Peoples R China
关键词
Insulin; MALDI MS; Antibody-enrichment; Chemical conjugation; MASS-SPECTROMETRY; BIOMARKER DISCOVERY; ENZYME-IMMUNOASSAY; PROTEOMICS; DIAGNOSTICS; CHEMISTRY; PROTEINS; SERUM;
D O I
10.1186/s12014-017-9139-z
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Detection of low-abundance biomarkers using mass spectrometry (MS) is often hampered by nontarget molecules in biological fluids. In addition, current procedures for sample preparation increase sample consumption and limit analysis throughput. Here, a simple strategy is proposed to construct an antibody-modified target plate for high-sensitivity MS detection of target markers such as insulin, in biological fluids. Methods: The target plate was first modified with gold nanoparticle, and then functionalized with corresponding antibody through chemical conjugation. Clinical specimens were incubated onto these antibody-functionalized target plates, and then subjected to matrix assisted laser desorption ionization mass spectrometry analysis. Results: Insulin in samples was enriched specifically on this functional plate. The detection just required low-volume samples (lower than 5 mu L) and simplified handling process (within 40 min). This method exhibited high sensitivity (limit of detection in standard samples, 0.8 nM) and good linear correlation of MS intensity with insulin concentration (R-2 = 0.994). More importantly, insulin present in real biological fluids such as human serum and cell lysate could be detected directly by using this functional target plate without additional sample preparations. Conclusions: Our method is easy to manipulate, cost-effective, and with a potential to be applied in the field of clinical biomarker detection.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 28 条
[1]  
Alexander GC, 2013, CLIN PROTEOM, V10, P20
[2]  
ANDERSEN L, 1993, CLIN CHEM, V39, P578
[3]  
Arruda DL, 2009, EXPERT REV MOL DIAGN, V9, P749, DOI [10.1586/erm.09.47, 10.1586/ERM.09.47]
[4]   PROBE IMMOBILIZED AFFINITY-CHROMATOGRAPHY MASS-SPECTROMETRY [J].
BROCKMAN, AH ;
ORLANDO, R .
ANALYTICAL CHEMISTRY, 1995, 67 (24) :4581-4585
[5]  
Brockman AH, 1996, RAPID COMMUN MASS SP, V10, P1688, DOI 10.1002/(SICI)1097-0231(199610)10:13<1688::AID-RCM717>3.0.CO
[6]  
2-3
[7]   Advances in top-down proteomics for disease biomarker discovery [J].
Calligaris, David ;
Villard, Claude ;
Lafitte, Daniel .
JOURNAL OF PROTEOMICS, 2011, 74 (07) :920-934
[8]   Towards proteome standards: The use of absolute quantitation in high-throughput biomarker discovery [J].
Chao, Tzu-Chiao ;
Hansmeier, Nicole ;
Halden, Rolf U. .
JOURNAL OF PROTEOMICS, 2010, 73 (08) :1641-1646
[9]   Sensitive Plasma Protein Analysis by Microparticle-based Proximity Ligation Assays [J].
Darmanis, Spyros ;
Nong, Rachel Yuan ;
Hammond, Maria ;
Gu, Jijuan ;
Alderborn, Anders ;
Vanelid, Johan ;
Siegbahn, Agneta ;
Gustafsdottir, Sigrun ;
Ericsson, Olle ;
Landegren, Ulf ;
Kamali-Moghaddam, Masood .
MOLECULAR & CELLULAR PROTEOMICS, 2010, 9 (02) :327-335
[10]   Self-assembled PEG monolayer based SPR immunosensor for label-free detection of insulin [J].
Gobi, K. Vengatajalabathy ;
Iwasaka, Hiroyuki ;
Miura, Norio .
BIOSENSORS & BIOELECTRONICS, 2007, 22 (07) :1382-1389